Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-12-26

Clinical Trial Update: The Effectiveness of Topical Latanoprost Compared With Topical Brimonidine in the Treatment of the Primary Open Angle Glaucoma [Phase 2]

View source ↗

Summary

Phase 2 trial comparing topical latanoprost to topical brimonidine for primary open-angle glaucoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Brimonidine (brimonidine)
  • Latanoprost (Latanoprost)

Snippet

Sponsor: Chittagong Medical College | Conditions: To See the Safety and Efficacy of the Topical Latanoprost Compared With Topical Brimonidine in the Treatment of the Primary Open Angle Glaucoma Patients | Phase 2 | Status: COMPLETED